Adma Biologics (ADMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -17,970 | -16,813 | -15,527 | -7,301 | N/A |
| Depreciation Amortization | 736 | 431 | 358 | 188 | N/A |
| Accounts receivable | -541 | -384 | 39 | -39 | N/A |
| Accounts payable and accrued liabilities | 203 | -938 | 1,609 | -245 | N/A |
| Other Working Capital | -671 | 178 | 3,438 | -437 | N/A |
| Other Operating Activity | 2,824 | 2,821 | -803 | 931 | 0 |
| Operating Cash Flow | $-15,418 | $-14,705 | $-10,887 | $-6,904 | $N/A |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 16,415 | N/A | -2,935 | N/A | N/A |
| PPE Investments | -26 | -2,323 | -197 | -119 | N/A |
| Purchase Of Investment | -18,130 | -1,718 | N/A | N/A | N/A |
| Investing Cash Flow | $-1,742 | $-4,041 | $-3,132 | $-119 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 16,000 | 9,850 | 1,000 | 3,906 | N/A |
| Debt Repayment | -15,315 | -13 | -12 | -210 | N/A |
| Common Stock Issued | 10,307 | N/A | 27,031 | 17,287 | N/A |
| Common Stock Repurchased | N/A | N/A | N/A | -150 | N/A |
| Other Financing Activity | -590 | -42 | -386 | -1,363 | 0 |
| Financing Cash Flow | $10,402 | $9,795 | $27,633 | $19,471 | $N/A |
| Beginning Cash Position | 17,199 | 26,150 | 12,536 | 88 | N/A |
| End Cash Position | 10,441 | 17,199 | 26,150 | 12,536 | N/A |
| Net Cash Flow | $-6,758 | $-8,950 | $13,614 | $12,448 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -15,418 | -14,705 | -10,887 | -6,904 | N/A |
| Capital Expenditure | -26 | -2,323 | -197 | -119 | N/A |
| Free Cash Flow | -15,445 | -17,028 | -11,084 | -7,023 | 0 |